las molestias. to let us know you're having trouble. The state pension system, which has backed four previous GTCR main buyout funds and two co-investments alongside the firm, is weighing a $50 million commitment to the newest fund, according to the documents. By submitting this request, you consent to receive email from Blackstone. Over the past 31 years, Biocoat has developed a diverse base of both blue-chip and emerging medical device customers, a highly experienced team of engineers and scientists, and state-of-the-art manufacturing and R&D facilities. [5][6] Golder Thoma & Cressey received much of its initial funding from William M. Blair and upon leaving First Chicago, Golder was replaced by John A. Canning, Jr. who would go on to found rival Chicago private equity firm Madison Dearborn. Latham & Watkins provided legal counsel to GTCR. When typing in this field, a list of search results will appear and be automatically updated as you type. Kirkland & Ellis LLP served as legal counsel and Baird served as financial advisor to GTCR. The fund supports GTCR's Leaders Strategy investment approach for smaller opportunities than those pursued by its most recent flagship fund, GTCR Fund XIII, which closed in 2020 with $7.5 . an. Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. GTCR is based in Chicago with offices in New York and West Palm Beach. 60654 GTCR is based in Chicago with offices in. Our top priority at GTCR has always been to serve our limited partners by working to generate strong and consistent investment returns through the disciplined application of our investment strategy. "Jim Moran and the Biocoat team have built an exciting platform company," said Chip Hance. In total, GTCR has invested in 31 US states and 5 different countries. Caso continue recebendo esta mensagem, GTCR LLC | 12,402 followers on LinkedIn. Si vous continuez voir ce Further information is available at www.blackstone.com. GTCR, a leading private equity firm, announced today that it has made a majority investment in PathGroup Holdings LLC ("PathGroup" or the "Company") in partnership with founder and CEO Ben Davis . para informarnos de que tienes problemas. The company was founded in 1980 as Golder Thoma & Co. by Stanley Golder, Carl Thoma, and Bryan Cressey. The Chicago-based firm pioneered - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions. The company provides clients with the highest quality of services available, consistently exceeding the expectations of physicians, employees, payers, and most importantly, patients. Privately held and physician-centric, PathGroup works seamlessly with customers to provide superior diagnostic services a vital link in the cycle of patient relationships. This website uses cookies, including third-party cookies, in order to obtain information about your visit to the website and make this website better. For office-specific contact information, please visit our our offices page. Blackstone Contact: Vivid Seats operates as an online ticket marketplace that connects fans with event ticket sellers. . 300 N. LaSalle Street, Suite 5600, PitchBooks data visualizations quickly surface an investors historical investmentsshowing a breakdown of activity by industry, year and region. For press inquiries, contact [emailprotected]. Otherwise, we will assume you're OK to continue. CHICAGO & NEW YORK--(BUSINESS WIRE)--GTCR LLC and Blackstone (NYSE:BX) today jointly announced a new partnership in which funds managed by Blackstones GP Stakes business will acquire a minority ownership interest in GTCR. The Company's capabilities include developing and supplying customized coatings formulations, performing coatings application services, and offering coatings equipment solutions. Founded in 1980, GTCR is a leading private equity firm that pioneered The Leaders Strategy finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions. About. real person. Kirkland & Ellis LLP served as legal counsel and Baird served as financial advisor to GTCR. medium-sized businesses in the United States and Canada. om ons te informeren over dit probleem. Get the full list, Youre viewing 5 of 216 team members. Since 2018, equity firm GTCR has been included on a list of defendants on a long and growing list of personal injury lawsuits related to alleged toxic emissions from the Sterigenics facility in west suburban Willowbrook. Founded in 1991 and headquartered in Horsham, Pennsylvania, Biocoat is a leading medical device contract manufacturing organization ("CMO"), specializing in custom, biocompatible hydrophilic coatings for interventional medical devices. Create Comparison. I have known the GTCR team for nearly a decade and we share a common vision and commitment to building PathGroup into a larger, more diversified business that can better serve our providers and their patients. CHICAGO, Nov. 10, 2020 /PRNewswire/ -- GTCR today announced the recent closing of its thirteenth equity fund, GTCR Fund XIII, with $7.5 billion of limited partner capital commitments.. GTCR Fund . Lamentamos Customer Service. Follow GTCR on LinkedIn. For more information, please visit www.gtcr.com. GTCR will also have access to a wide range of other services Blackstone provides internally and to its portfolio companies that leverage Blackstones scale and expertise, including its ESG, sustainability, human capital management, cybersecurity, and product development capabilities. Funding. GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications. About BlackstoneBlackstone is the worlds largest alternative asset manager. GTCR has had 23 exits. Its largest (disclosed) acquisition occurred in 2021 when it acquired Wells Fargo Asset Management for $2.1B. Please click here if you would like more information about the cookies used on this website and how to change your cookie settings. Join Mergr to view GTCRs full profile and discover more Finally, we have a talented group of investment professionals and staff, and we are dedicated to providing our team with the most opportunity for professional growth and impact, while working in a collaborative and inclusive environment. A Leader in Private Equity for Over 40 Years | Founded in 1980, GTCR is a leading private equity firm that pioneered The Leaders Strategy - finding . Biocoat's custom hydrophilic coatings are lubricious, abrasion resistant, biocompatible and can be applied to a wide range of polymeric and metallic substrates. Chicago, IL and New York, NY July 27, 2021 GTCR LLC and Blackstone (NYSE:BX) today jointly announced a new partnership in which funds managed by Blackstones GP Stakes business will acquire a minority ownership interest in GTCR. The Company's capabilities include developing and supplying customized coatings formulations, performing coatings application services, and offering coatings equipment solutions. You may change your billing preferences at any time in the Customer Center or call TheChicago-based firm pioneered The Leaders Strategy - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. GTCR has deep expertise in the healthcare and lab testing industries and will leverage its prior investment history and resources to help support the continued growth of the Company alongside the PathGroup team. We are sorry for the inconvenience. For more information, please visit www.gtcr.com. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Over the past 15 months, we have made three Financial Services & Technology ("FS&T") platform investments: Optimal Blue, RevSpring and Sage Payment Solutions. The Chicago-based firm pioneered The Leaders Strategy - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. This platform enables the Company to work with its customers across a wide range of interventional products and medical device segments, including neurovascular, ophthalmology, cardiovascular and other interventional specialties. Evercore served as financial advisor to GTCR. GTCRs most common sectors for investment arehealthcare services (16%) and information technology (12%) . Revenue: $500 million to $1 billion (USD) Competitors: Allston Trading, Infinium Capital Management, Rothschild & Co. Claim as much as 50% Off - Best Buy Coupon, Epsteins Private Calendar Reveals Prominent Names, First Republic Bank Is Seized and Bulk Sold to JPMorgan, Fed Set to Raise Rates to 16-Year High and Debate a Pause, Opinion: Randi Weingartens Incredible Covid Memory Loss, Opinion: The Fed Failed but Wants More Power, Opinion: Politico Aims at Gorsuch and Misses, JPMorgan Buys First Republic Bank in Second-Largest U.S. Bank Failure, WSJ Opinion: The Teachers Union Says: 'Don't Blame Us', Why the Fed Raises Interest Rates to Deal With Inflation, WSJ Opinion: Feeling Lucky, Democrats Back Non-Compos Presidential Politics, FBI Raises Reward for Texas Shooting Suspect: We Have Zero Leads. We've known Dave King and Ben Davis for a long time and are excited to partner with them and support the Company in its next chapter of growth.". This platform enables the Company to work with its customers across a wide range of interventional products and medical device segments, including neurovascular, ophthalmology, cardiovascular and other interventional specialties. Under Mr. Hance's leadership, Resonetics has completed 10 add-on acquisitions, generated significant organic growth, and executed a successful partial sale for a minority stake of Resonetics at a $2.25 billion enterprise value in November 2021. In 1978, the US Labor Department relaxed certain of the ERISA restrictions, under the "prudent man rule," a fiduciary responsibility of investment managers under ERISA. About GTCR Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Healthcare, Financial Services & Technology, Technology, Media & Telecommunications, and Growth Business Services industries. GTCR has raised 1 round. I have been personally gratified to develop rapport with the GTCR team, and we look forward to our long-term partnership., Ward Young, GP Stakes Managing Director added, Our top priority is to partner with the most successful general partners in private equity. GTCR is the current iteration of an equity and investment corporate finance entity dating back to the 1970s. GTCR is based in Chicago with offices in New York and West Palm Beach. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. In particular, we believe that this investment partnership will further enhance our ability to serve the interests of our limited partners, our management partners and our investment team and staff. To explore GTCRs full profile, request access. Blackstones GP Stakes business specializes in value-added, long-term partnerships with leading private-market alternative asset management firms. Both firms continue to invest primarily through consolidations of specific industries, referred to as roll-ups: GTCR invests through a series of private limited partnerships and its investors include a variety of pension funds (e.g., Washington State Investment Board,[12] Pennsylvania State Employee's Retirement System[13]) endowments and other institutional investors. CHICAGO, Nov. 2, 2022 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has made a strategic, majority investment in Biocoat Holdings, LLC ("Biocoat" or the. The Firm looks to grow companies through build-on acquisitions, consolidations, and internal growth. This is a profile preview from the PitchBook Platform. In 1998, disagreements between the senior partners led Golder, Thoma, Cressey, Rauner, Inc. split into two private equity firms. The firm became Golder Thoma & Cressey in 1984, and with the promotion of Bruce Rauner to partner the firm would come to be known as Golder, Thoma, Cressey, Rauner, Inc. (GTCR), although it would still often be referred to as Golder Thoma.[7]. As part of GTCRs Leaders StrategyTM, we seek to identify and partner with talented, accomplished executives with whom we work collaboratively to build and grow our portfolio companies. CHICAGO and NASHVILLE, Tenn., May 13, 2022 /PRNewswire/ --. We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them. Contact Information Website www.gtcr.com Formerly Known As Golder, Thoma, Cressey, Rauner Year Founded 1980 Investor Status Actively Seeking New Investments Trade Association Illinois Venture Capital Association (IVCA2) Private Equity Council (PEC) Win whats next. naar Piper Sandler served as exclusive financial advisor to Biocoat. Since its inception, GTCR has invested more than $20 billion in over 250 companies. GTCR has made 42 investments. Which industries has this organization had the most exits in? Follow us on LinkedIn. As part of GTCR's Leaders Strategy, Dave King, the former Chairman and CEO of Labcorp, will join the PathGroup Board as Chairman, partnering with Dr. Davis and GTCR to further invest in PathGroup's capabilities across the pathology, molecular, and genetic diagnostics modalities. GTCR is a leading growth-oriented private equity firm with a management-driven approach and business-building investment orientation. ", "Dr. Davis and the PathGroup team have done an incredible job of building PathGroup intoa unique, scaled lab services business with outstanding clinical services," said Sean Cunningham, Managing Director and Co-Head of Healthcare at GTCR. excuses voor het ongemak. Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie Founded in 1991, Biocoat is a leading provider of medical coatings products and services for medical devices in the fast-growing interventional sector. About GTCR Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Healthcare, Financial Services & Technology, Technology, Media . "Jim Moran and the Biocoat team have built an exciting platform company," said Chip Hance. GTCRs largest (disclosed) exit occurred in 2020 when it sold Optimal Blue for $1.8B. This sale includes Wells Fargo Bank N.A.'s business of acting as trustee to its collective investment trusts and all related WFAM legal entities. Individual Investors & Financial Advisors. Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, GTCR Becomes Signatory to United Nations-Supported Principles for Responsible Investment. GTCR is a leading growth-oriented private equity firm with a management-driven approach and business-building investment orientation. Pritzker Private Capital and Vesey Street Capital Partners will also be retaining a minority ownership stake in the Company alongside GTCR and the PathGroup management team. Under Mr. Hance's leadership, Resonetics has completed 10 add-on acquisitions, generated significant organic growth, and executed a successful partial sale for a minority stake of Resonetics at a $2.25 billion enterprise value in November 2021. Beyond providing capital and financial acumen, with deep sector expertise, GTCR utilizes its depth of resources and passion to drive results to help companies grow into industry leaders. "We look forward to supporting the team and expanding the PathGroup platform through organic growth initiatives and additional strategic acquisitions. CONTACT: Kellie Kennedy, [emailprotected], 312-933-4903, Cision Distribution 888-776-0942 Chicago, Going forward, the existing Biocoat management team, led by CEO Jim Moran, will continue in their existing roles executing on Biocoat's growth initiatives in partnership with GTCR. About GTCRFounded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications industries. Wells Fargo Company (NYSE: WFC) today announced that it has entered into a definitive agreement to sell Wells Fargo Asset Management (WFAM) to GTCR LLC and Reverence Capital Partners, L.P. Prior to partnering with GTCR, Mr. Hance served as Chief Executive Officer of Creganna Medical, a leading supplier of contract manufacturing services for medical devices, where he significantly grew the business via acquisitions and organic growth before completing a successful sale of the company in 2016 to TE Connectivity. Contact:Kellie Kennedy312-933-4903[emailprotected], Cision Distribution 888-776-0942 Jim TenBroek is a co-founder and Managing Partner of GCP. You may cancel your subscription at anytime by calling Follow Blackstone on Twitter @Blackstone. Our $684 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. United States We do this by using extraordinary people and flexible capital to help companies solve problems. We are especially impressed with GTCRs strategy of investing in transformative growth behind talented executives. Wenn CHICAGO, Nov. 2, 2022 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has made a strategic, majority investment in Biocoat Holdings, LLC ("Biocoat" or the "Company"). Ironshore Insurance provides broker-sourced specialty property and casualty insurance coverages for varying risks. The firm principally invests in high-growth industries, including financial services & technology, healthcare, information services & technology, and growth business services. Kirkland & Ellis served as legal counsel to GTCR and Fried Frank served as legal counsel to Blackstone. los inconvenientes que esto te pueda causar. Si continas viendo este mensaje, For more information, please visit www.gtcr.com. 1 Under the terms of the agreement, the purchase price is . Based in Nashville, Tennessee, PathGroup is one of the largest independent laboratories in the United States. CHICAGO, Nov. 2, 2022 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has made a strategic, majority investment in Biocoat Holdings, LLC ("Biocoat" or the "Company . Wir entschuldigen uns fr die Umstnde. GTCR Fund XII, the firm's largest fund to date, with $5.25 billion of limited partner equity capital commitments. Aydanos a proteger Glassdoor verificando que eres una persona real. "Biocoat has an excellent track record of developing high-quality biocompatible medical coatings formulations using innovative technologies, and we look forward to investing additional capital to support both organic initiatives and strategic follow-on acquisitions in the medical coatings and broader biomaterials sector," said GTCR Managing Director Luke Marker. GTCR is a prolific health care investor, with at least 11 current health care portfolio companies and almost 50 past investments. Which types of acquisition does this organization make most frequently. Piper Sandler served as exclusive financial advisor to Biocoat. To ensure the most secure and best overall experience on our website we recommend the latest versions of, Internet Explorer is no longer supported. GTCR's checkered history in health care raises questions . GTCR understands the dynamics of business transformation through acquisitions, consolidations and internal growth. Since its inception, GTCR has invested more than $24 billion in over 270 companies, and the firm currently manages over $27 billion in equity capital. The partnership will provide GTCRs portfolio companies with access to Blackstones group purchasing program, which leverages the buying power of the $150 billion revenue base across Blackstones entire investment platform. Follow Blackstone on Twitter @Blackstone. Switchboard:+1 (212) 583-5000. envie um e-mail para Blackstone is an exceptional institution and we expect they will bring resources and perspective that will help us as we continue to serve our limited partners, build our franchise and invest our funds over the long term. "Biocoat has an excellent track record of developing high-quality biocompatible medical coatings formulations using innovative technologies, and we look forward to investing additional capital to support both organic initiatives and strategic follow-on acquisitions in the medical coatings and broader biomaterials sector," said GTCR Managing Director Luke Marker. The Chicago-based firm pioneered The Leaders Strategy finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth.